Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal.
about
Menopause, the metabolic syndrome, and mind-body therapiesImpaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice.Effects of different doses of physical activity on C-reactive protein among womenBehavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise trainingSerum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat.Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb.Reproducibility of serum cytokines and growth factorsEnvironmental tobacco smoke exposure and diabetes in adult never-smokers.Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosusIntra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening TrialMetabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trialFactors associated with inflammation markers, a cross-sectional analysis.Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortInsulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposityEfficacy of Trigonella foenum-graecum Seed Extract in Reducing Metabolic and Inflammatory Alterations Associated With MenopauseThe role of estrogens in control of energy balance and glucose homeostasis.Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study.Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome.Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.Detectability and reproducibility of plasma levels of chemokines and soluble receptors.The roles of the immune system in women's reproduction: evolutionary constraints and life history trade-offs.Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors.Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.Effects of a 12-month multi-component exercise program on the body composition of postmenopausal women.Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome.Waist circumference and menopausal status are independent predictors of endothelial low-grade inflammation.The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.Estrogen replacement raises rat CRP without evidence of complement activation.Serum C-reactive protein and plasma homocysteine levels are associated with hormone therapy use and other factors: a population-based study of middle-aged Australian-born women.Endothelial dysfunction occurs independently of adipose tissue inflammation and insulin resistance in ovariectomized Yucatan miniature-swine.Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis.Sleep quality and duration are related to microvascular function: the Amsterdam Growth and Health Longitudinal Study.Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.Estrogen receptor activation, TNF-α, and endothelial dysfunction: can we keep our interest in estrogens awake?Effect of raloxifene and atorvastatin in atherosclerotic process in ovariectomized rats.Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension
P2860
Q30437308-E209E1CB-1409-4929-A623-1563A626BA4FQ33655519-AF0E08FF-0C87-4878-91D0-D2270B5EC465Q33937339-80512ED2-A763-4653-916A-05A80BE05C69Q33938878-9CFD1E48-4429-4F81-A027-2962B23BC58BQ33993042-C15D7396-FF49-49EF-8CD5-75A654BD378CQ34215079-97305A9B-DCB9-4773-9439-7D3708F99556Q34305127-4E476C27-6ABE-4F4D-AE6B-D7533C508FF1Q34318445-EA7940C2-102D-4293-9DFF-956AC42412B6Q34402670-45291A5C-0AAF-4AA5-BC56-D3A54D294826Q34785060-1385F676-54D6-45AE-B9E5-4B1DBC671E12Q35194978-06D0F11C-60E8-4315-963D-479DE5184767Q35255717-CB977432-FFCC-40C7-AC32-ED9B33E25C74Q35507040-562384E3-7B60-4B08-B206-3C291835B4ACQ35633792-904D4FDB-367E-4FC3-8ECD-53D7AE14A346Q35680361-0D1F3644-40D6-4925-AB34-0B5356A0EC79Q35728222-0B51BC9D-C2A9-4EB5-94F8-9F8AC3DED946Q36422236-F20444D0-7E4F-46A3-8F4F-B5B104AB2A9DQ36864744-FAAD8E76-8F83-44C8-A1D5-969B43BB46A0Q37016839-4596E473-8D21-456A-8B73-FCD8FDCC2182Q37069367-7F3C345E-906C-4609-93FA-8115B42147A6Q37471083-B6791137-8DE6-429D-8E64-C309FD1F390DQ37536250-57B03B40-1E57-42EA-98F0-958CC213F53AQ37958705-60E0A2C5-D063-4174-B935-A5097156341FQ38107072-CF04186F-7DCA-4A3D-BE48-AAD73768C40AQ38511940-8216FC22-6A6D-4DF5-AD71-CAD14197CFBCQ44402880-D9BBB744-EABC-4886-9D1E-4778975401AEQ45241793-2FFAFAB6-FBA4-4AC6-B8E5-BAA922E9132DQ46578770-97CFFA5B-7F7E-4F8F-9AF7-F53DF0138493Q46797831-D8DC20BD-1892-4182-A031-F0D7E47FD778Q46851818-B4922F36-0FAD-4991-A603-2907A9B20204Q46877655-5F8CCC97-52E7-4BE4-B366-3CDF52F8B6FCQ47250030-094BDAD5-0E75-49BF-B67A-94333CACC9D0Q47820890-B61E7A66-EAF8-4CD3-9B2C-37D5A7EED001Q48016324-E6952B46-D2AF-4804-9B2D-4944C6406658Q50551487-310D9F04-3A79-4133-A2BD-1E63388FB4B0Q50953393-9CDBE614-AE40-4F01-AE93-5DF9EC098157Q51321737-3C8FC4AE-3149-476D-ACD5-07E314323D81Q57551556-BD7461BB-AF66-47BB-A0A8-FBC44EA9DDBE
P2860
Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Menopause-related differences ...... n-stimulated glucose disposal.
@en
Menopause-related differences ...... n-stimulated glucose disposal.
@nl
type
label
Menopause-related differences ...... n-stimulated glucose disposal.
@en
Menopause-related differences ...... n-stimulated glucose disposal.
@nl
prefLabel
Menopause-related differences ...... n-stimulated glucose disposal.
@en
Menopause-related differences ...... n-stimulated glucose disposal.
@nl
P2093
P1476
Menopause-related differences ...... n-stimulated glucose disposal.
@en
P2093
André Tchernof
Cynthia K Sites
Eric T Poehlman
Georgia D L'Hommedieu
Michael J Toth
Russell P Tracy
P304
P356
10.1016/S0015-0282(01)02934-X
P407
P50
P577
2002-01-01T00:00:00Z